Glucose and Fructose Stimulated Brain Activity in Obese Subjects
Not Applicable
Completed
- Conditions
- Exploratory Behavior
- Registration Number
- NCT02589613
- Lead Sponsor
- University Hospital, Basel, Switzerland
- Brief Summary
The objective is to investigate neuro-anatomical correlates of the regulation of energy intake by means of functional MRI. Administration of glucose as well as fructose is followed by functional brain MRI, and findings are correlated with serum glucagon-like peptide 1 (GLP-1) levels as an endogenous satiety signal in obese humans.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 12
Inclusion Criteria
- right-handed healthy males, no drugs, non-smoking
Exclusion Criteria
- drug abuse, smoker, left-handed, claustrophobia
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method Functional magnetic resonance imaging (fMRI) in healthy, obese volunteers while they performed a working memory task: changes in cerebral blood flow changes from baseline to one hour after treatment
- Secondary Outcome Measures
Name Time Method Changes in plasma insulin changes from baseline to one hour after treatment Changes in plasma GLP-1 changes from baseline to one hour after treatment Changes in plasma glucose changes from baseline to one hour after treatment
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the differential effects of glucose and fructose on brain activity in obesity?
How do GLP-1 levels correlate with brain region activation after glucose or fructose ingestion in obese individuals?
Are there specific biomarkers that predict satiety response to glucose versus fructose in metabolic disorders?
What adverse events are associated with acute glucose and fructose administration in obese human trials?
How do glucose and fructose ingestion effects compare to standard-of-care appetite regulation interventions in obesity?